Results 101 to 110 of about 15,738 (196)

Comparator pH study to evaluate the single-dose pharmacodynamics of dual delayed-release dexlansoprazole 60 mg and delayed-release esomeprazole 40 mg

Clinical and Experimental Gastroenterology, 2011
Michael Kukulka1, Corey Eisenberg2, Sai Nudurupati31Clinical Pharmacology, 2Clinical Science, 3Statistics, Takeda Global Research & Development Center Inc, Deerfield, IL, USABackground: This paper describes a Phase 1, single-center, randomized ...
Kukulka M, Eisenberg C, Nudurapati S
doaj  

Kosten en effecten van esomeprazol in de behandeling van reflux ziekte [PDF]

, 2002
Doel. Het bepalen van de kosten-effectiviteit van esomeprazol (Nexium(r)) ten opzichte van alle andere in Nederland geregistreerde protonpomp remmers in de behandeling van reflux ziekte.
Al, M.J. (Maiwenn), Buijt, I., Rutten, F.F.H. (Frans)   +2 more
core  

Esomeprasol in the treatment of duodenal ulcer under various regimens of antihelicobacter therapy

Терапевтический архив, 2003
Aim. To assess efficiency of esomeprazole in the treatment of duodenal ulcer (DU) associated with Hpylori in various eradication regimens. Material and methods. 80 patients with duodenal ulcer at least 0.5 cm in diameter were randomized into three groups.
I V Maev, A E Kurilo, E S Vyuchnova, M I Schekina   +3 more
doaj  

“INDICACIONES CLÍNICAS DE LOS INHIBIDORES DE LA BOMBA DE PROTONES” (REVISIÓN BIBLIOGRÁFICA) [PDF]

, 2013
Los inhibidores de la bomba de protones (IBP), son los fármacos más potentes y eficaces para el control de la secreción acida gástrica y están dentro de los grupos farmacológicos más prescritos para el tratamiento de enfermedades relacionadas con la ...
Cárdenas González, Tania Alejandra, Jaimes García, Javier   +1 more
core  

Treatment and prophylaxis of NSAID-induced gastropathies in a therapeutist’s practice

Российский журнал гастроэнтерологии, гепатологии, колопроктологии, 2009
The aim of review – to present up-to-date data on application of proton pump inhibitors (PPI) e.g. esomeprazole for treatment and prophylaxes of gastropathies, induced by intake of nonsteroid anti-inflammatory drugs (NSAIDs).Original positions. PPI serve
T. L. Lapina
doaj  

Analysis of Clinical Predictors of Resolution of Sleep Disturbance Related to Frequent Nighttime Heartburn and Acid Regurgitation Symptoms in Individuals Taking Esomeprazole 20 mg or Placebo [PDF]

, 2016

core   +1 more source

A case of probable esomeprazole-induced transient liver injury in a pregnant woman with hyperemesis

Clinical Pharmacology: Advances and Applications, 2016
Binny Thomas,1-3 Mahmoud Mohamed,1,3,4 Moza Al Hail,1-3 Fatma Alzahra Y Awwad,1 Ramy M Wahba,1 Sabir B Hassan,1 Khalid Omar,1 Wessam El Kassem,1 Palivalappila Abdul Rouf1 1Hamad Medical Corporation, Doha, Qatar; 2Robert Gordon University, Aberdeen ...
Thomas B, Mohamed M, Al Hail M, Awwad FA, Wahba RM, Hassan SB, Omar K, El Kassem W, Abdul Rouf P   +8 more
doaj  

The safety, pharmacodynamics, and pharmacokinetics of immediate-release formulation containing esomeprazole 20 mg/sodium bicarbonate 800 mg in healthy adult male

Drug Design, Development and Therapy, 2019
Dasohm Kim1,2, Min Soo Park1,2, Byung Won Yoo2, Taegon Hong2, Shin Jung Park3, Choon Ok Kim2 1Department of Pharmaceutical Medicine and Regulatory Sciences, College of Medicine and Pharmacy, Yonsei University, Incheon, Korea; 2Department of Clinical ...
Kim D, Park MS, Yoo BW, Hong T, Park SJ, Kim CO   +5 more
doaj  

Tegoprazan in Gastroesophageal Reflux Disease and Related Acid-Mediated Conditions: A Systematic Review and Meta-Analysis. [PDF]

JGH Open
Bandyopadhyay S, Goenka M, Routh D, Ramesh GN, Lawate P.   +4 more
europepmc   +1 more source

Efficacy and safety of ilaprazole for stress ulcer - associated upper gastrointestinal bleeding prophylaxis in critically ill patients: a randomized, double-blind, non-inferiority phase 3 trial. [PDF]

Ann Intensive Care
Liu J, Pan X, Huang S, Fu S, Cui Y, Yang J, Hou X, Xia Y, Zhang S, Wen Z, Sun H, Xiao Y, Li H, Shang W, Yu X, Chen D.   +15 more
europepmc   +1 more source